UnknownNCT03591315
Clinical Study of Structural and Functional Evaluation of the Visual Pathway
Studying Cerebral visual impairment
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Xiangya Hospital of Central South University
- Principal Investigator
- Liu Z Xiong, MD/PhDNeurosurgery department, Xiangya Hospital of Central South University, Changsha, Hunan, China
- Intervention
- resting state fMRI(diagnostic_test)
- Enrollment
- 60 enrolled
- Eligibility
- 18-60 years · All sexes
- Timeline
- 2018 – 2019
Study locations (1)
- Xiangya Hospital of Central South University, Changsha, Hunan, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03591315 on ClinicalTrials.govOther trials for Cerebral visual impairment
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07134777Mechanisms of Visual Restoration After Occipital StrokeUniversity of Rochester
- ENROLLING BY INVITATIONNCT07212010Neurodevelopmental Outcomes in Cerebral Visual ImpairmentChildren's Hospital Medical Center, Cincinnati
- RECRUITINGNANCT07105358Visual Plasticity Following Brain LesionsGeorgetown University
- RECRUITINGNCT07275021Cerebral/ Cortical Visual Impairment: Screening, Identification and Outcome Prediction in NeonatesBrigham and Women's Hospital
- RECRUITINGNCT06997354Validation of a Parental Questionnaire for Screening Children for Neurovisual DisordersUniversité Catholique de Louvain
- RECRUITINGNANCT06701617In-person and Telehealth Visual Rehabilitation for Children With Low VisionNational Taiwan University Hospital
- ACTIVE NOT RECRUITINGNCT06636994Anatomical and Functional Predictions of Blindsight Capabilities in Patients With Lateral HemianopsiaFondation Ophtalmologique Adolphe de Rothschild
- ENROLLING BY INVITATIONNANCT06578117Statistical Learning as a Novel Intervention for Cortical BlindnessUniversity of Rochester